Companies must have a realistic understanding of the timeframes and effort involved.
Before officially beginning down a path to non-GMO verification, manufacturers should consult with a technical administrator or verifying body to “identify risks and uncover potential obstacles” that lie ahead, offers Heroux. This pre-planning and initial consultation can help to improve efficiencies and reduce costs once the manufacturer is enrolled in a program.
Data collection is another important pre-enrollment step. Manufacturers are advised to use a standardized data-collection tool, such as the forms used by the technical administrator. Relevant data to capture will include disclosures of additives, carriers, enzymes, microorganisms, fermentation media, raw material sources, and non-GMO manufacturing systems, Heroux explains.
Next, enrollment of products should be ordered beginning with best-sellers or product formulas that include various high-GMO-risk ingredients. (Aspartame, citric acid, high-fructose corn syrup, sucrose, xanthan gum, and lactic acid are examples of ingredients commonly derived from GMO-risk crops or “produced with genetically modified inputs,” Heroux warns.) This approach also helps familiarize staff with what will be required of ingredient suppliers, eases the severity of the learning curve, and lessens the workload of the quality department, she adds.
<<Previous Next>>
Photo © iStockphoto.com/frender
Senate Committee has released the text of 2024 Farm Bill, with changes to hemp regulations
November 19th 2024The U.S. Senate Committee on Agriculture, Nutrition, & Forestry has introduced the Rural Prosperity and Food Security Act, which will serve as the Senate’s draft for the 2024 Farm Bill.
NPA’s lawsuit against FDA on NMN stayed pending agency’s decision on citizen petition
November 6th 2024The court has granted a joint motion for stay filed by NPA and FDA, pending the agency's decision on the citizen petition asking FDA to reverse its stance on NMN's status as a dietary ingredient.